Bicycle Therapeutics (50BA) Q2 2026 Earnings Report
DE:50BA Q2 2026 EPS Results
- Actual EPS
- -EUR 0.64
- Consensus EPS
- -EUR 0.51
- Beat/Miss
- Missed by -EUR 0.13
- One Year Ago EPS
- -EUR 1.02
DE:50BA Q2 2026 Revenue Results
- Actual Revenue
- EUR 562.34K
- Expected Revenue
- EUR 3.77M
- Beat/Miss
- Missed by -EUR 3.20M
- YoY Revenue Growth
- -78.68%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/30/2026
- Time
- Before Open
- Conference Call
- Thursday, July 30, 2026
DE:50BA Upcoming Earnings
Bicycle Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:50BA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.39- | -0.26 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.36-0.13 | -0.76 | 82.35% (+0.62) | |
| Jul 30, 2026 | 2026 (Q2) | -0.51-0.64 | -1.02 | 36.84% (+0.37) | |
| Apr 30, 2026 | 2026 (Q1) | -0.55-0.78 | -0.79 | 1.14% (+0.01) | |
| Mar 17, 2026 | 2025 (Q4) | -0.84-0.26 | -0.67 | 61.33% (+0.41) | |
| Oct 30, 2025 | 2025 (Q3) | -0.96-0.76 | -0.66 | -14.86% (-0.10) | |
| Aug 08, 2025 | 2025 (Q2) | -0.84-1.02 | -0.69 | -48.05% (-0.33) | |
| May 01, 2025 | 2025 (Q1) | -0.75-0.79 | -0.55 | -41.94% (-0.23) | |
| Feb 25, 2025 | 2024 (Q4) | -0.76-0.67 | -1.04 | 35.34% (+0.37) | |
| Oct 31, 2024 | 2024 (Q3) | -0.71-0.66 | -1.12 | 41.27% (+0.46) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed